SCHEMBL9426618

SCHEMBL9426618

CCCNC(=S)Nc1cnccc1N

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ LMNA P02545 3/20 0.51
▸ SMN1; SMN2 Q16637 5/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MAPT P10636 3/20 0.42
▸ ALOX12 P18054 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ GALR3 O60755 1/20 0.41
▸ NR2F2 P24468 1/20 0.41
▸ KDM6B O15054 1/20 0.41
▸ KDM4C Q9H3R0 1/20 0.41
▸ QPCT Q16769 1/20 0.38
▸ BCL6 P41182 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9426614 0.92 LMNA (0.62) HTTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL9426257 0.88 ALDH1A1 (0.49) HTTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL9425432 0.80 ALDH1A1 (0.45) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
Hydrochloric Acid SCHEMBL9426498 0.78 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2KMT2AMAPT
SCHEMBL9586194 0.76 LMNA (0.43) HTTALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL3068769 0.76 KDM4C (0.57) GAAKDM6BKDM4C
SCHEMBL9425715 0.76 SMN1; SMN2 (0.43) HTTALDH1A1LMNASMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL9425881 0.75 SMN1; SMN2 (0.42) HTTALDH1A1LMNASMN1; SMN2KMT2A
SCHEMBL6988265 0.74 CYP1A2 (0.41) ALDH1A1KMT2ACYP1A2MAPTGAA
Hydrochloric Acid SCHEMBL9426022 0.73 CYP1A2 (0.40) ALDH1A1CYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371086-A Circulatory disorders side effect reduction THE GREEN CROSS CORPORATION (JP) 1994-12-06 — — US disclosed
US-5262415-A FOR TREATING DISEASES OF THE CIRCULATORY SYSTEM THE GREEN CROSS CORPORATION (JP) 1993-11-16 — — US disclosed
EP-0503627-A1 Aminopyridine compounds THE GREEN CROSS CORPORATION (JP) 1992-09-16 — — EP disclosed
Send feedback